Scribe Therapeutics Inc.

NASDAQ: SCTX · Healthcare · Biotechnology

PublicHQ Alameda, CA · AlamedaReports USD

#1 of 1,413 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 37

v0.1 · 5/100 weight · pillars only

↑ market scale, listing tenure · ↓ listing tenure, market scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

Market cap

$350.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Scribe Therapeutics Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Enanta Pharmaceuticals, Inc.55C Opus Genetics, Inc.38D Benitec Biopharma Inc.47D Ovid Therapeutics Inc.49D

Neighbors

Alameda →

Lam Research Corporation$18.4B85A Ross Stores, Inc.$22.8B79B+Block, Inc.$24.2B69B PG&E Corporation$24.9B71B Workday, Inc.$9.6B80B+Veeva Systems Inc.$3.2B86A

Key facts

CEOBenjamin L. Oakes

SectorHealthcare

IndustryBiotechnology

HeadquartersAlameda, CA

ExchangeNASDAQ: SCTX

Employees—

IPO date2026-07-24

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.